Company intelligence / Profile preview

Ronglian Group

Ownership: Private
Development stage: Other

Overview

Ronglian Group is a leading Chinese provider of enterprise digital transformation solutions with core strengths in data center integration, IT infrastructure, and industry-specific digital services. It operates across finance, government utilities, energy/manufacturing—and maintains a dedicated bio-medical segment focused on biological cloud platforms. The group has established nationwide coverage with regional centers and offices throughout China. No clinical results are reported as it does not develop drugs or therapies directly.

Modalities: Biological cloud platform
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Dassault Systèmes

Beyond the preview

Go deeper on Ronglian Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ronglian Group.

Explore the full profile